Innovation Advisory Committee
As the primary goal of ENRIITC is to enhance RI-industry collaborations, the ENRIITC Innovation Advisory Committee (IAC) is made up of 6 successful representatives of industry, industry associations and innovation ecosystems. Given their various expertises, they will give input on the project strategy and its implementation and will be consulted for advise on various tasks.
He has also been active in fund raising by creating the services provider company ALTA, particularly successful in the field of health sciences, which obtained several grants from the European Commission. He was the representative of Italy in the creation of the Innovative Medicines Initiative (IMI), the largest Public-Private Partnership in the world.
In the vaccine field, he co-founded the Novartis Vaccine Institute for Global Health in Siena, Italy, and served as a member of the Programme/Policy Committee of the Global Alliance for Vaccine Immunization (GAVI). The most recent achievement obtained with his scientific management support is the creation, within the Toscana Life Science Foundation in Siena, of a research laboratory that is currently developing human monoclonal antibodies against SARS-CoV-19. Furthermore, he collaborated with CureVac in Tübingen to prepare a project proposal aimed to developing vaccines with an innovative mRNA technology. This project is now funded by the Coalition for Epidemic Preparedness Innovations (CEPI) with a grant for € 34 M, which recently has been further increased to support activities for the identification and production of a vaccine for Covid-19.